Evaluation of transcatheter arterial embolization (TAE) as a therapy for recurrence of heputocelluler carcinoma after hepatic resection

We analized nineteen patients suffering from recurrent hepatocellular carcinoma after hepatic resection. They were divided into two groups by postrecurrence therapy, performed with transcatheter arterial embolization (TAE) or not. TAE was performed in twelve patients (TAE group) and the other therapies were performed in seven patients (non-TAE group). On the hepatic resection and recurrence there was no significant difference in the several factors for prognosis between the groups of TAE and non-TAE. Nevertheless, one-and two-year survival rate after recurrence were 91%, 57% in the TAE group, respectively. There was significant difference (p